Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 9
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Özden, Hale T. 2016. Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey. European Journal of Gastroenterology & Hepatology, Vol. 28, Issue. 3, p. 333.

    Inoue, Jun Ueno, Yoshiyuki Nagasaki, Futoshi Akahane, Takehiro Fukushima, Koji Kogure, Takayuki Kondo, Yasuteru Kakazu, Eiji Tamai, Keiichi Kido, Osamu Nakagome, Yu Ninomiya, Masashi Obara, Noriyuki Wakui, Yuta Takahashi, Masaharu Okamoto, Hiroaki and Shimosegawa, Tooru 2009. Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan. Journal of Gastroenterology, Vol. 44, Issue. 4, p. 329.

    Tsatsralt-Od, Bira Takahashi, Masaharu Endo, Kazunori Agiimaa, Dondog Buyankhuu, Osorjin and Okamoto, Hiroaki 2007. Comparison of hepatitis A and E virus infections among healthy children in Mongolia: Evidence for infection with a subgenotype IA HAV in children. Journal of Medical Virology, Vol. 79, Issue. 1, p. 18.

    Mitsui, Takehiro Tsukamoto, Yukie Hirose, Akinori Suzuki, Shigeru Yamazaki, Chikao Masuko, Kazuo Tsuda, Fumio Endo, Kazunori Takahashi, Masaharu and Okamoto, Hiroaki 2006. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. Journal of Medical Virology, Vol. 78, Issue. 8, p. 1015.

    Sagnelli, E. Stroffolini, T. Almasio, P. Mele, A. Coppola, N. Ferrigno, L. Scolastico, C. Onofrio, M. Imparato, M. and Filippini, P. 2006. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study*. Journal of Viral Hepatitis, Vol. 13, Issue. 1, p. 67.

    Sagnelli, E. Coppola, N. Pisaturo, M. Pisapia, R. Onofrio, M. Sagnelli, C. Catuogno, A. Scolastico, C. Piccinino, F. and Filippini, P. 2006. Clinical and Virological Improvement of Hepatitis B Virus--Related or Hepatitis C Virus--Related Chronic Hepatitis with Concomitant Hepatitis A Virus Infection. Clinical Infectious Diseases, Vol. 42, Issue. 11, p. 1536.

    Iorio, Raffaele Sepe, Angela Giannattasio, Antonietta Cirillo, Francesco and Vegnente, Angela 2005. Hypertransaminasemia in childhood as a marker of genetic liver disorders. Journal of Gastroenterology, Vol. 40, Issue. 8, p. 820.

    Gandolfo, Giuseppe M. Ferri, Giovanni M. Conti, Laura Antenucci, Anna Marrone, Rosalia Frasca, Anna M. and Vitelli, Gaetano 2003. Prevalence of infections by hepatitis A, B, C and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolivia. Medicina Clínica, Vol. 120, Issue. 19, p. 725.

    Sagnelli, Evangelista Coppola, Nicola Marrocco, Cecilia Onofrio, Mirella Scarano, Ferdinando Marotta, Anna Scolastico, Carlo Catuogno, Antonio Salzillo, Angela Sagnelli, Caterina Piccinino, Felice and Filippini, Pietro 2003. HAV replication in acute hepatitis with typical and atypical clinical course. Journal of Medical Virology, Vol. 71, Issue. 1, p. 1.


Antibodies to hepatitis A virus in Italian patients with chronic liver disease

  • E. SAGNELLI (a1), G. ROSSI (a1), N. COPPOLA (a1), C. SCOLASTICO (a1), M. ONOFRIO (a1), P. FILIPPINI (a1), M. CHIARAMONTE (a2), E. PIZZIGALLO (a3), A. ACETI (a4), A. SPADARO (a5), G. RAIMONDO (a6) and F. PICCININO (a1)
  • DOI:
  • Published online: 26 November 2001

To improve our knowledge for future hepatitis A virus (HAV) vaccination strategies we carried out a multicentre study on naturally acquired immunological protection against HAV in patients with chronic hepatitis in Italy. We enrolled 830 consecutive patients with chronic hepatitis on their first observation at one of the six Italian liver units participating in the study. Six hundred and fifty-eight patients (79·3%) were positive for total anti-HAV and 172 (20·7%) were negative. The anti-HAV negative patients were younger (median age 33, range 11–78) than the anti-HAV positive (median age 56, 18–87). There was a higher prevalence of cases with circulating anti-HAV among the 508 patients residing in southern Italy than in the 322 residing in northern Italy (88·8% vs. 64%, P < 0·001). No significant difference in the anti-HAV prevalence was observed between patients from northern Italy and those from southern Italy aged 0–30 years or in those over 60 years, while in those 31–60 years old there was a higher prevalence of anti-HAV positive patients from southern Italy (90·2% vs. 65·8%, P < 0·0001). Of the patients with liver cirrhosis in this study, only 3 of the 26 (11·5%) from northern Italy and 8 of the 228 (3·5%) from southern Italy had no immunological protection against HAV infection. The data suggest that the number of patients with chronic liver disease without naturally acquired immunity against HAV is substantial in Italy, particularly in the north of the country, and that new vaccination strategies are needed.

Corresponding author
Author for correspondence: Institute of Infectious Diseases, Second University of Naples, c/o Ospedale Gesù e Maria, via D. Cotugno 1, 80135, Naples, Italy.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *